CEFETAMET PIVOXIL IN THE SURGICAL FIELD
-
- MORIMOTO KEN
- Second Department of Surgery, Osaka City University, School of Medicine
-
- KINOSHITA HIROAKI
- Second Department of Surgery, Osaka City University, School of Medicine
-
- NAKATANI SHUICHI
- Second Department of Surgery, Osaka City University, School of Medicine
-
- SAKAI KATSUJI
- Osaka City University
-
- FUJIMOTO MIKIO
- Department of Surgery, Fujiidera Municipal Hospital
-
- OHNO KOICHI
- Department of Surgery, Fujiidera Municipal Hospital
-
- UEDA TAKAMI
- Department of Surgery, Haruki Foundation Hospital
-
- MORIMOTO YUZURU
- Department of Surgery, Higashisumiyoshi Morimoto Hospital
-
- HIRATA SANAE
- Department of Surgery, Osaka Municipal Shirokita Hospital
-
- MURAMATSU HIDEYUKI
- Department of Surgery, Osaka Municipal Shirokita Hospital
-
- MIYAMOTO TOU
- Department of Surgery, Osaka Municipal Momoyama Hospital
-
- YAMAZAKI OSAMU
- Department of Surgery, Osaka Municipal Momoyama Hospital
Bibliographic Information
- Other Title
-
- 外科領域感染症に対するcefetamet pivoxilの臨床使用経験
Abstract
We clinically investigated a new oral cephalosporin, cefetamet pivoxil, with the following results.<BR>1) Thirty-three patients with surgical infections were enrolled in this study, and 31 were eligible for evaluation.<BR>2) Of the 31 assessable patients, clinical response was excellent in 13, good in 8, fair in 6 and poor in 4 cases, and the efficacy rate was 67.7%.<BR>3) This drug is best prescribed against infections caused by Gram-negative aerobic rods, not by Gram-positive cocci.<BR>4) The recommended dose is 1, 000mg daily.
Journal
-
- CHEMOTHERAPY
-
CHEMOTHERAPY 38 (Supplement1), 314-321, 1990
Japanese Society of Chemotherapy
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282681262901248
-
- NII Article ID
- 130004072765
-
- ISSN
- 18845894
- 00093165
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed